Insulin secretion and its modulation by antiarrhythmic and sulfonylurea drugs

Cardiovascular Research

Volumn 34, Issue 1, 1997, Pages 69-72

  Horie, Minoru ^a,b   Ishida Takahashi, Ayako ^a   Ai, Tomohiko ^a   Nishimoto, Toshihisa ^a   Tsuura, Yoshiyuki ^a   Ishida, Hitoshi ^a   Seino, Yutaka ^a   Sasayama, Shigetake ^a  

^a KYOTO UNIVERSITY   (Japan)

^b KYOTO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Antiarrhythmic drugs; ATP sensitive; Potassium channel; Sulfonylureas

Indexed keywords

ADENOSINE TRIPHOSPHATE; ANTIARRHYTHMIC AGENT; CIBENZOLINE; DISOPYRAMIDE; GLIBENCLAMIDE; POTASSIUM CHANNEL; SULFONYLUREA;

BINDING SITE; CELL MEMBRANE; GLUCOSE TRANSPORT; HYPOALBUMINEMIA; HYPOGLYCEMIA; INSULIN LIKE ACTIVITY; INSULIN RELEASE; PANCREAS ISLET BETA CELL; PATCH CLAMP; POTASSIUM CONDUCTANCE; POTASSIUM CURRENT; PRIORITY JOURNAL; REVIEW;

3T3 CELLS; ANIMALS; ANTI-ARRHYTHMIA AGENTS; ATP-BINDING CASSETTE TRANSPORTERS; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; ISLETS OF LANGERHANS; MICE; POTASSIUM CHANNELS; POTASSIUM CHANNELS, INWARDLY RECTIFYING; RECEPTORS, DRUG; SULFONYLUREA COMPOUNDS;

EID: 0030960869     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0008-6363(97)00014-X     Document Type: Review

References (42)

1. Goldberg U, Brown LK, Rayfield EJ. Disopyramide-induced hypo- glycemia. Am J Med 1980;69:463-466.
2. Semel JD, Wortham E, Karl DM. Fasting hypoglycemia associated with disopyramide. Am Heart J 1983;106:1160-1161.
3. Croxson MS, Shaw DW, Henley PG, Gabriel HDLL. Disopyramide-induced hypoglycaemia and increase serum insulin. NZ Med J 1987;100:407-408.
4. Hilleman DE, Mohiuddin SM, Ahmed IS, Dahl JM. Cibenzoline-in- duced hypoglycemia. Drug Intell Clin Pharmacol 1987;21:38-40.
5. Jeandel C, Preiss MA, Pierson H, et al. Hypoglycaemia induced by cibenzoline. Lancet 1988;8596:1232-1233.
6. Lefort G, Haissaguerre M, Floro J, et al. Hypoglycémie au cours de surdosages par un nouvel anti-arrhythmique: la cibenzoline; trois observations. Presse Méd 1988;17:687-691.
7. Garchot BA, Bezier M, Cherrier JF, Daubeze J. Cibenzoline and hypoglycemia. Lancet 1988;8605:280.
8. Houndent C, Noblet C, Fandoren C, et al. Hypoglycemia induced by cibenzoline in the elderly. Rev Méd Interne 1991;12:143-145.
9. Phillips RE, Looareesuwan S, White NJ, et al. Hypoglycaemia and antimalarial drugs: quinine and release of insulin. Br Med J 1986;292:1319-1321.
10. Okitolonda W, Delacollette C, Malengreau M, Henquin JC. High incidence of hypoglycemia in African patients treated with intravenous quinine for severe malaria. Br Med J 1987;295:716-718.
11. + channels in insulin-secreting cells. FEBS Lett 1985;185:4-8.
12. + channels in mouse pancreatic β-cells by external tetraethylammonium and quinine. J Physiol 1990;423:327-342.
13. Horie M, Hayashi S, Yuzuki Y, Sasayama S. Comparative studies of ATP-sensitive K channels in heart and pancreatic β-cells using Vaughan Williams class la antiarrhythmics. Cardiovasc Res 1992;26:1087-1094.
14. + channels and enhances insulin release. Am J Physiol 1993;265:C337-C342.
15. Kakei M, Nakazaki M, Kamisaki T, et al. Inhibition of the ATP-sensitive potassium channel by class I antiarrhythmic agent, cibenzoline, in rat pancreatic β-cells. Br J Pharmacol 1993;109:1226-1231.
16. + channels and insulinotrophic action by antiarrhythmic agent cibenzoline. Br J Pharmacol 1996;117:1749-1755.
17. + channels in cardiac muscle. Nature 1983;305:147-148.
18. + channels in pancreatic β-cells. Nature 1984;311:269-271.
19. Ashcroft FM, Harrison DE, Ashcroft SJH. Glucose induces closure of single potassium channels in isolated rat pancreatic β-cells. Nature 1984;312:446-448.
20. + channel in pancreatic β-cells are regulated by intracellular ATP. Pflügers Arch 1985;405:305-309.
21. Misler S, Falke LC, Gillis K, MacDaniel ML. A metabolite-regulated potassium channel in rat pancreatic β cells. Proc Natl Acad Sci USA 1986;83:7119-7123.
22. 2+ concentration in pancreatic β-cells. J Biol Chem 1987;262:5448-5454.
23. Ashcroft FM. Adenosine 5′-triphosphate-sensitive potassium channels. Annu Rev Neurol 1988;11:97-118.
24. Henquin JC. D-Glucose inhibits potassium efflux from pancreatic islet cells. Nature 1978;271:271-273.
25. Henquin JC. Tolbutamide stimulation and inhibition of insulin release: Studies of the underlying ionic mechanisms in isolated rat islet. Diabetologia 1980;18:151-156.
26. Sturgess N, Ashford ML, Cook DL, Hales-CN. The sulfonylurea receptor may be an ATP-sensitive potassium channel. Lancet 1985;8453:474-475.
27. + channel in mouse pancreatic β-cells. Pflügers Arch 1986;407:493-499.
28. Aguilar-Bryan L, Nichols CG, Wechsler SW, et al. Cloning of the β-cell high-affinity sulfonylurea receptor. Science 1995;268:423-426.
29. Anderson MP, Gregory RJ, Thompson S, et al. Demonstration that CFTR is a chloride channel by alteration of its anion selectivity. Science 1991;253:202-205.
30. KATP: an inward rectifier subunit plus the sulfonylurea receptor. Science 1995;270:1166-1170.
31. Inagaki N, Tsuura Y, Namba N, et al. Cloning and functional characterization of a novel ATP-sensitive potassium channel ubiquitously expressed in rat tissues, including pancreatic islets, pituitary, skeletal muscle, and heart. J Biol Chem 1995 ;270:5691-5694.
32. Ammälä C, Moorhouse A, Gribble F, et al. Promiscuous coupling between the sulphonylurea receptor and inwardly rectifying potassium channels. Nature 1996;379:545-548.
33. + channel Kir6.1 expressed in human embryonic kidney cells. J Physiol 1996;494:709-714.
34. Bertrand G, Gross R, Petit P, et al. Evidence for a direct stimulatory effect of cibenzoline on insulin secretion in rats. Eur J Pharmacol 1992;214,159-163.
35. Massarella LW, Khoo K, Szuna AJ, et al. Pharmaco-kinetics of cibenzoline after single and repetitive dosing in healthy volunteers. J Clin Pharmacol 1986;263:125-130.
36. + channels that are inhibited by ATP in an insulin-secreting cell line. FEBS Lett 1986;208:59-62.
37. + channels in rat pancreatic β-cells is modulated by ADP. FEBS Lett 1986;208:63-66.
38. Zünkler BJ, Trübe G, Fanten U. How do sulfonylureas approach their receptor in the β-cell plasma membrane? Naunyn-Schmiedeberg's Arch Pharmacol 1989;340:328-332.
39. + channels in cardiac muscle by the sulfonylurea drug glibenclamide. J Pharmacol Exp Ther 1992;261:540-545.
40. + channels in cardiac muscle. J Pharmacol Exp Ther 1992;262:71-79.
41. Groop LC. Sulfonylureas in NIDDM. Diabetes Care 1992;15:737-754.
42. + channels during metabolic stress in cardiac muscle. J Pharmacol Exp Ther 1993;256:456-468.